How much does Cabozantinib cost per box?

The original drug Cabozantinib has not yet been launched in China, so there is no official price in the domestic market and it cannot be reimbursed through medical insurance. For domestic patients, if they need to use the drug, they usually need to purchase it through overseas channels or seek imported drug supply from hospitals, which involves many factors such as price, transportation and exchange rate. The specifications of the original cabozantinib drug and generic drugs provided in overseas markets are relatively diverse, with tablets and capsule preparations available, and the price differences are obvious.

In Hong Kong, common specifications of cabozantinib tablets include20mg 30 tablets, 40mg 30 tablets and 60mg*30 tablets. Each box sells for about 50,000 yuan. In other overseas regions, such as Japan, Turkey and Europe, the original version of the drug is available in both tablet and capsule forms. Tablets are sold for about 30,000 yuan per box, and capsule preparations are sold for about 40,000 yuan per box. Due to exchange rate fluctuations and regional differences, specific prices may be adjusted.

In addition, generic drugs of cabozantinib are also available in overseas markets. The efficacy is basically the same as that of the original drug, providing patients with a more economical choice. For example, the 20mg*90 tablets produced by Laos United Pharmaceuticals may sell for less than 1,000 yuan per box; Indian and Bangladeshi versions of generic drugs are also on the market, with lower prices but similar efficacy. This provides a reference for domestic patients to import through legal channels, but they still need to pay attention to the formality of drug sources and drug quality monitoring.

Generally speaking, cabozantinib lacks formal sales channels and medical insurance coverage in China. If patients want to use it, they need to choose the appropriate method based on their own economic situation, treatment needs and accessibility. When formulating medication plans, clinicians will also comprehensively evaluate drug efficacy, patient tolerance and economic factors to provide patients with individualized treatment recommendations.

Reference:https://en.wikipedia.org/wiki/Cabozantinib